Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation
暂无分享,去创建一个
H. Williams | M. Dattani | I. Robinson | S. Camper | M. Harakalova | W. Qasim | S. Rahman | G. van Haaften | C. B. Ferreira | D. Kelberman | P. Shah | L. Gregory | C. Gaston-Massuet | GOSgene | T. Dever | Sara K. Young-Baird
[1] B. Shin,et al. MEHMO syndrome mutation EIF2S3-I259M impairs initiator Met-tRNAiMet binding to eukaryotic translation initiation factor eIF2 , 2018, Nucleic acids research.
[2] M. Skopkova,et al. Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome. , 2018, Physiological research.
[3] S. Haas,et al. EIF2S3 Mutations Associated with Severe X‐Linked Intellectual Disability Syndrome MEHMO , 2017, Human mutation.
[4] L. Gregory. Investigation of new candidate genes in a cohort of patients with familial congenital hypopituitarism and associated disorders , 2017 .
[5] H. Pendeville,et al. Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy , 2016, American journal of medical genetics. Part A.
[6] Colin Echeverría Aitken,et al. Conformational Differences between Open and Closed States of the Eukaryotic Translation Initiation Complex , 2015, Molecular cell.
[7] Alan G Hinnebusch,et al. The scanning mechanism of eukaryotic translation initiation. , 2014, Annual review of biochemistry.
[8] P. Flatt,et al. Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemia , 2013, Islets.
[9] A. Munnich,et al. eIF2γ mutation that disrupts eIF2 complex integrity links intellectual disability to impaired translation initiation. , 2012, Molecular cell.
[10] M. Hamid,et al. Configuration of electrofusion-derived human insulin-secreting cell line as pseudoislets enhances functionality and therapeutic utility. , 2012, The Journal of endocrinology.
[11] R. Schiffmann,et al. Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter , 2012 .
[12] E. Cuppen,et al. Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing , 2011, Nature Protocols.
[13] A. Hinnebusch,et al. Molecular Mechanism of Scanning and Start Codon Selection in Eukaryotes , 2011, Microbiology and Molecular Reviews.
[14] R. Gomis,et al. Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion* , 2011, The Journal of Biological Chemistry.
[15] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[16] C. Cao,et al. Translation Initiation Factor 2γ Mutant Alters Start Codon Selection Independent of Met-tRNA Binding , 2008, Molecular and Cellular Biology.
[17] F. Urano,et al. The Role of Nitric Oxide and the Unfolded Protein Response in Cytokine-Induced β-Cell Death , 2008, Diabetes.
[18] Y. Mechulam,et al. Structure of an archaeal heterotrimeric initiation factor 2 reveals a nucleotide state between the GTP and the GDP states , 2007, Proceedings of the National Academy of Sciences.
[19] A. Hinnebusch. Translational regulation of GCN4 and the general amino acid control of yeast. , 2005, Annual review of microbiology.
[20] D. Scheuner,et al. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis , 2005, Nature Medicine.
[21] M. Katze,et al. Pancreatic (cid:1) -Cell Failure and Diabetes in Mice With a Deletion Mutation of the Endoplasmic Reticulum Molecular Chaperone Gene P58 IPK , 2022 .
[22] Wei Li,et al. Mutations Linked to Leukoencephalopathy with Vanishing White Matter Impair the Function of the Eukaryotic Initiation Factor 2B Complex in Diverse Ways , 2004, Molecular and Cellular Biology.
[23] E McEwen,et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. , 2001, Molecular cell.
[24] U. Müller,et al. MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to Xp21.1–p22.13 , 1998, European Journal of Human Genetics.
[25] Han-kuei Huang,et al. GTP hydrolysis controls stringent selection of the AUG start codon during translation initiation in Saccharomyces cerevisiae. , 1997, Genes & development.
[26] R. Wek,et al. The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids , 1995, Molecular and cellular biology.
[27] D. Dorris,et al. Mutations in GCD11, the structural gene for eIF‐2 gamma in yeast, alter translational regulation of GCN4 and the selection of the start site for protein synthesis. , 1995, The EMBO journal.
[28] T. Kinzy,et al. GCD11, a negative regulator of GCN4 expression, encodes the gamma subunit of eIF-2 in Saccharomyces cerevisiae , 1993, Molecular and cellular biology.
[29] A. Hinnebusch,et al. Association of RAP1 binding sites with stringent control of ribosomal protein gene transcription in Saccharomyces cerevisiae , 1991, Molecular and cellular biology.
[30] A. Cigan,et al. Genetic selection for mutations that reduce or abolish ribosomal recognition of the HIS4 translational initiator region , 1988, Molecular and cellular biology.
[31] G. Natsoulis,et al. 5-Fluoroorotic acid as a selective agent in yeast molecular genetics. , 1987, Methods in enzymology.
[32] A. Hinnebusch. A hierarchy of trans-acting factors modulates translation of an activator of amino acid biosynthetic genes in Saccharomyces cerevisiae , 1985, Molecular and cellular biology.